secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enhabit, Inc. (EHAB)
CIK:        0001803737
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001803737-24-000052
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enhabit concludes strategic review without sale; Q1 rev $262.4M, Adj. EBITDA $25.3M
--------------------------------------------------------------------------------

- Board ends strategic alternatives review, will remain independent; no formal proposals received.
- Q1 net income $0.2M, diluted EPS $0.01; adjusted EPS $0.07.
- Total admissions up 5.3% YoY; non-Medicare home health admissions up 25.2%.
- Reaffirms FY 2024 guidance: revenue $1.076-1.102B, Adj. EBITDA $98-110M.
- Four legacy Encompass board members to not stand for election in 2024, reducing board to 9.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1803737/000180373724000052/0001803737-24-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1803737/000180373724000052/ehab-20240508.htm
  HTML page:      https://secwatch.observer/filing/0001803737-24-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer